Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database

Despite receiving a number of injections within a TAE range, a substantial proportion of eyes failed to achieve extended treatment intervals at 12 and 24 months (61.8% and 52.9%, respectively). These results underscore the significant unmet therapeutic need in the management of nAMD with currently approved first-generation anti-VEGF agents.

Authors

Institutions

Publication Details

Journal
Eye
Published
2025-10-16
DOI
https://doi.org/10.1038/s41433-025-03996-8
Citations
2
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
3.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database

Gonzaga Garay‐Aramburu, Carolina Arruabarrena, Laura Sararols-Ramsay, Pilar Calvo et al.
2 citations
Eye
Retinal Diseases and Treatments
3.41
article

Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database

Gonzaga Garay‐Aramburu, Carolina Arruabarrena, Laura Sararols-Ramsay, Pilar Calvo, Miguel Ángel Zapata, Javier Zarranz‐Ventura, Pablo Arnáiz, Paula García-Lunar
article en
2 citations

Abstract

Despite receiving a number of injections within a TAE range, a substantial proportion of eyes failed to achieve extended treatment intervals at 12 and 24 months (61.8% and 52.9%, respectively). These results underscore the significant unmet therapeutic need in the management of nAMD with currently approved first-generation anti-VEGF agents.

EyeVol. 39(18)
Universidade da Coruña (ES), University of the Basque Country (ES), Hospital Universitario La Paz (ES), Bellvitge University Hospital (ES), Hospital Costa del Sol (ES), Clínica Rementería (ES), Hospital de Nens de Barcelona (ES), Hospital de Basurto (ES), Hospital de La Ribera (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Ajuntament de L’Hospitalet (ES), Hospital Universitario Príncipe de Asturias (ES), Hospital Universitario Araba (ES), IVI Valencia Clinic (ES), Hospital General de Granollers (ES), Hospital Universitario Miguel Servet (ES), Hospital Clínic de Barcelona (ES), Hospital Universitario Virgen de las Nieves (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Hospital Universitario de La Princesa (ES), Hospital Del Mar (ES), Hospital de Sant Joan Despí Moisès Broggi (ES), Clinica Universidad de Navarra (ES), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES), Hospital de Cruces (ES), Hospital Universitario del Vinalopó (ES), Hospital Quirón Torrevieja (ES), IVI Sevilla Clinic (ES), Roche (Spain) (ES), Hospital Universitario del Henares (ES), Hospital Universitario Virgen del Rocío (ES), Hospital Universitari Germans Trias i Pujol (ES), Fundació Clínic per a la Recerca Biomèdica (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Ramón y Cajal (ES), Hospital Provincial de Conxo (ES), Universitat de Barcelona (ES), Universidad de Sevilla (ES)
Openalex Percentile: Top 7%
Retinal Diseases and Treatments
3.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.